Key result
Equine brain GM3 gangliosides contain ~18% N-glycolyl neuraminic acid, an exceptional mammalian CNS finding.
Why the study?
Equine brain gangliosides were characterized to determine whether they contain N-glycolyl neuraminic acid, unlike other mammals whose brain gangliosides predominantly have N-acetyl neuraminic acid.
The study demonstrates the exceptional presence of N-glycolyl neuraminic acid as a minor component in equine brain gangliosides (specifically GM3), unlike other mammalian central nervous systems.
No takes yet. Share an insight, caveat, or question.
Minor NeuGc-GM3 in equine brain cautions against uniform mammalian CNS assumptions; leaves open species-specific sialic acid roles.
Mikami et al. (1998) studied this question. Isolation and characterization of equine brain gangliosides was evaluated on Presence of N-glycolyl neuraminic acid in equine brain gangliosides. Equine brain GM3 gangliosides were found to possess N-glycolyl neuraminic acid as a minor component (18% of total GM3), an exceptional finding in the mammalian central nervous system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: